WO2015066335A1 - Parent radionuclide container - Google Patents

Parent radionuclide container Download PDF

Info

Publication number
WO2015066335A1
WO2015066335A1 PCT/US2014/063167 US2014063167W WO2015066335A1 WO 2015066335 A1 WO2015066335 A1 WO 2015066335A1 US 2014063167 W US2014063167 W US 2014063167W WO 2015066335 A1 WO2015066335 A1 WO 2015066335A1
Authority
WO
WIPO (PCT)
Prior art keywords
vial
case
tube
stopper
radiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2014/063167
Other languages
English (en)
French (fr)
Inventor
Glenn H. ISENSEE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northstar Medical Radioisotopes LLC
Original Assignee
Northstar Medical Radioisotopes LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northstar Medical Radioisotopes LLC filed Critical Northstar Medical Radioisotopes LLC
Priority to AU2014342210A priority Critical patent/AU2014342210B2/en
Priority to EP14857501.2A priority patent/EP3063770B1/en
Priority to CA2927365A priority patent/CA2927365C/en
Priority to CN201480059511.9A priority patent/CN105684092B/zh
Priority to KR1020167012470A priority patent/KR102325245B1/ko
Priority to JP2016552238A priority patent/JP6549138B2/ja
Publication of WO2015066335A1 publication Critical patent/WO2015066335A1/en
Priority to ZA2016/02676A priority patent/ZA201602676B/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21FPROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR
    • G21F5/00Transportable or portable shielded containers
    • G21F5/015Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation units; Radioisotope containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096Combination of a vial and a syringe for transferring or mixing their contents
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21FPROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR
    • G21F5/00Transportable or portable shielded containers
    • G21F5/015Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation units; Radioisotope containers
    • G21F5/018Syringe shields or holders
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21FPROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR
    • G21F5/00Transportable or portable shielded containers
    • G21F5/06Details of, or accessories to, the containers
    • G21F5/12Closures for containers; Sealing arrangements
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/0005Isotope delivery systems

Definitions

  • the field of the invention relates to nuclear medicine and more particularly, to methods of processing radioactive nuclides.
  • radioactive materials in nuclear medicine for therapeutic and diagnostic purposes are known.
  • radioactive material may be used to track blood flow for purposes of detecting obstructions or the like.
  • the radioactive material e.g., a tracer
  • the radioactive material may be injected into a vein of the arm or leg of a person.
  • a scintillation camera may be used to collect images of the person following the injection.
  • the gamma rays of the tracer interact with a detector of the camera to create images of the person.
  • a series of images are collected as the tracer perfuses through the person. Since the tracer diffuses through the blood of the person, the veins or arteries with greater blood flow produce a greater signature from the tracer.
  • radioactive material may be coupled at a molecular level with a biolocalization agent.
  • the biolocalization agent may concentrate the radioactive material at some specific location (e.g., the site of a tumor).
  • Radioactive materials Key to the use of radioactive materials in nuclear medicine is the creation of nuclear materials with a relatively short half life (e.g., 2-72 hours).
  • the short half life causes the radioactivity to decay rapidly in such as way as to reduce exposure of the person to radiation.
  • FIG. 1 is a front, perspective view of a device for processing radionuclides shown generally in accordance with an illustrated embodiment of the invention
  • FIG. 2 is block diagram of the processing element of the device of FIG. 1;
  • FIG. 3 is a simplified view of the parent radionuclide container of FIG. 2;
  • FIG. 4 is a side perspective view of the parent container of FIG. 2;
  • FIGs. 5A-B are back and a top cut-away views of the parent radionuclide container of FIG. 4;
  • FIGs. 6A-B are top and cut-away view of the parent radionuclide container of
  • FIG. 4
  • FIG. 7 is an expanded, cut-away view of the parent radionuclide container of FIGs. 4-6;
  • FIG. 8 is a side perspective view of a parent radionuclide container under an alternate embodiment.
  • FIG. 9 is a cutaway view of the container of FIG. 8.
  • FIG. 1 is a front perspective view of the device and system 10 for processing radionuclides shown generally in accordance with an illustrated embodiment of the invention.
  • FIG. 2 is a block diagram of the separation system 10.
  • the system 10 may be used to provide highly pure radioactive materials for use in diagnostic or therapeutic processes.
  • the system 10 may be constructed as a portable device that is simple to use in radionuclide production facilities, nuclear pharmacies or in some other medical environment.
  • the system 10 may be used to separate a parent radionuclide from a daughter radionuclide using a forward COW process and where the daughter radionuclide is produced by the decay of the parent radionuclide.
  • the system 10 may also be used to separate a daughter radionuclide from a parent radionuclide using a reverse COW process.
  • the separation column 28 may be selected for purification of a wide range of
  • the separation columns 26, 36 may be filled within a chromatographic material (e.g., ion- exchange resin, extraction chomotographic material, etc.) targeted for the specific radionuclide needed.
  • the system 10 may be used for the purification of yttrium-90, bismuth-212 and 213, or rhenium-188 for radiotherapy or technetium-99 m, thallium-201, fluorine- 18 or indium-I l l for diagnostic imaging.
  • the system 10 may be provided with a parent radionuclide. After some period of time, some of the parent radionuclide will decay to produce a mixture of parent and daughter radionuclides.
  • a controller 34 of the system 10 may activate one or more valves 22, 24, 26 and a pump 30 to transport the mixture of the parent and daughter radionuclides from a parent radionuclide container 12 to a first separation column 28 that captures the daughter radionuclide. Once the mixture of parent and daughter radionuclides has passed through the separation column 28, the remaining parent may be transported back to the parent container 12.
  • the controller 34 may wash the first separation column 28 by activating valves 22, 24 to first withdraw a wash solution from a processing fluids container 14, 16 and then to discard the wash solution into a waste container 18, 20.
  • the wash process may be repeated any of a number of times with the same or different types of wash solutions.
  • the controller 34 may withdraw a stripping solution from one of the processing fluids containers 14, 16 and then pump the stripping solution through the first separation column 28, through valve 26 and into the product cartridge assembly 32.
  • the stripping solution functions to release the daughter radionuclide from the separator column 28 and then transport the daughter radionuclide into the product cartridge assembly 32.
  • FIG. 3 is a simplified view of the storage container 12 of FIG. 2 for a parent radionuclide.
  • the storage unit includes a storage bottle or vial 56 in a radiation resistant case (e.g., lead) 50.
  • the radiation resistant case includes an aperture extending from an exterior into the case with a stopper 58 on an outside of the case extending into the aperture.
  • the stopper and case define a sterile venting channel that couples an interior of the case to the exterior of the case through a filter disposing through a first aperture in the stopper.
  • a fill tube is coupled between a second aperture in the stopper and the storage bottle, the fill tube extends along a portion of the venting channel from the stopper 58 to the storage bottle 56. Once the storage bottle is filled through the fill tube, a plug is inserted into the second aperture to maintain sterility.
  • the sterile tube is removed from its protective package and the plug is removed from the second aperture of the stopper.
  • the sterile tube is then inserted through the second aperture and the fill tube into the storage bottle.
  • the parent radionuclide may then be removed from the storage bottle and case through the sterile tube.
  • the storage container 12 may include one or more layers 50, 52 of shielding of various materials.
  • an inner shield 52 may be of a lighter material (e.g., polyethylene) for low energy particles.
  • An outer shield 50 may be a more dense material (e.g., lead) for high energy particles.
  • the bottle or vial 56 containing the parent radionuclide is disposed inside an inner chamber 54 of the container 12.
  • the stopper 58 extends through the outer shield 50.
  • a first tube 62 extends through the inner shield 52.
  • the first tube 62 extends through a cap 64 of the vial 56 on a first end and connects to the stopper 58 on a second end.
  • the second tube 60 is inserted into and threaded through the stopper 58 and first tube 62 to the bottom of the vial 56.
  • the pump 30 of FIG. 2 withdraws the parent radionuclide from the container 12 through the tube 60.
  • FIG. 4 depicts a side perspective view of the container 12.
  • FIGs. 5A is a rear view of the container 12.
  • FIG. 5B is a cut-away view of the container 12 of FIG. 5 A along section C-C.
  • FIG. 6A is a top view of the container 12 and
  • FIG. 6B is a cut-away view of the container 12 of FIG. 6 A along section A- A.
  • the container 12 is specifically constructed to prevent any form of line-of- sight radiation from exiting the container 12.
  • the outer shield 50 has an offset or jog 66 that prevents radiation to escaping the container 12 along the otherwise straight line of the seam between opposing halves of the outer shield 50.
  • the stopper 58 is arranged at an angle that is offset from the vial 56. Offset in this context means that a line passing down through the central bore or channel of the stopper 58 would not pass through any part of the vial 56. In this way radiation cannot propagate in a straight line from the vial 56 and through the central bore of the stopper 58 to irradiate a person handling the container 12.
  • the first tube 62 is also curved as it extends from the vial 56 to the stopper 58. In this way radiation cannot propagate in a straight line from the vial 56 up the first tube 62 and through the stopper 58.
  • the curve in the first tube 62 further operates to reduce radiation leakage.
  • FIG. 7 is an enlarged cut-away view of the container 12. As shown in FIG. 7, a vent passageway 66 extends diagonally and downwards to the left from the stopper 58. A sterile filter 68 is disposed in the stopper 58 and connects between the vent passageway 66 and the exterior of the container 12. A plug 70 is inserted into the central opening of the stopper 58 to prevent contaminants from entering the container 12 during shipping.
  • FIG. 8 depicts another embodiment of the storage container 12.
  • FIG. 9 is a cutaway side view of the container of FIG. 8.
  • the storage container may include an outer shielding layer 102 of a metallic substance (e.g., tungsten) and an inner shielding layer 104 of a lighter material (e.g., plastic).
  • a metallic substance e.g., tungsten
  • an inner shielding layer 104 of a lighter material e.g., plastic
  • the container of FIG. 9 may include a curved passageway 110 that connects the vial inside the container with an aperture extending through the outer wall of the container.
  • a tube 112 that is slightly smaller (e.g., 1/16") extends from the aperture to the top of the vial. The tube allows the vial to be filled while the slightly larger passageway allows air to escape from the vial as it is filled.
  • a plug 108 is inserted into the aperture.
  • a removable cap 106 prevents accidental removal of the plug.
  • the removable cap may have an aperture covered by a filter that allows the pressure inside the vial to equalize with atmospheric pressure
  • the first tube 112 allows a second, slightly smaller tube to be inserted through the first tube and into the vial.
  • the second, slightly smaller may be connected with the tube 60 of FIG. 1 for removal of the parent material from the container 12 for preparation of the daughter radionuclide.
  • providing the container includes providing a radiation impervious case, disposing a vial that holds a parent radionuclide within the case, venting the vial along a curved path between the vial and a stopper that is external to the case and connecting a fill tube between the vial and external stopper, said fill tube at least partially following the curved path of the vent.
  • the system includes a container suited for a parent radionuclide, the container further includes a radiation impervious case, a vial disposed within the radiation impervious case that holds the parent radionuclide within the case, a passageway extending along a curved path between the vial and a stopper that is external to the case and a fill tube that extends along the passageway between the vial and external stopper, said fill tube at least partially following the curved path of the vent.

Landscapes

  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PCT/US2014/063167 2013-10-30 2014-10-30 Parent radionuclide container Ceased WO2015066335A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AU2014342210A AU2014342210B2 (en) 2013-10-30 2014-10-30 Parent radionuclide container
EP14857501.2A EP3063770B1 (en) 2013-10-30 2014-10-30 Parent radionuclide container
CA2927365A CA2927365C (en) 2013-10-30 2014-10-30 Parent radionuclide container
CN201480059511.9A CN105684092B (zh) 2013-10-30 2014-10-30 用于处理母体放射性核素的装置及方法
KR1020167012470A KR102325245B1 (ko) 2013-10-30 2014-10-30 모핵종 컨테이너
JP2016552238A JP6549138B2 (ja) 2013-10-30 2014-10-30 親放射性核種容器
ZA2016/02676A ZA201602676B (en) 2013-10-30 2016-04-19 Parent radionuclide container

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361897489P 2013-10-30 2013-10-30
US61/897,489 2013-10-30

Publications (1)

Publication Number Publication Date
WO2015066335A1 true WO2015066335A1 (en) 2015-05-07

Family

ID=53005126

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/063167 Ceased WO2015066335A1 (en) 2013-10-30 2014-10-30 Parent radionuclide container

Country Status (9)

Country Link
US (1) US9281089B2 (https=)
EP (1) EP3063770B1 (https=)
JP (1) JP6549138B2 (https=)
KR (1) KR102325245B1 (https=)
CN (1) CN105684092B (https=)
AU (1) AU2014342210B2 (https=)
CA (1) CA2927365C (https=)
WO (1) WO2015066335A1 (https=)
ZA (1) ZA201602676B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2697656C1 (ru) * 2018-12-28 2019-08-16 Акционерное общество "Федеральный центр ядерной и радиационной безопасности" (АО ФЦЯРБ) Способ длительного сухого хранения отработавшего ядерного топлива и контейнер для его реализации
CN114902350A (zh) 2019-12-05 2022-08-12 塞控斯公司 生产高纯度212Pb
CN111477374B (zh) * 2020-05-29 2024-08-23 成都纽瑞特医疗科技股份有限公司 一种封闭式操作放射性核素的容器及方法
US20260083981A1 (en) * 2022-09-09 2026-03-26 Shl Medical Ag A shielded flexible bag for delivering radioactive medicaments, a shielded medication delivery cassette for radioactive medicaments and a shielded tubing set for administration of radioactive medicaments

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3369121A (en) * 1966-04-06 1968-02-13 Squibb & Sons Inc Radioactive package and container therefor
US5109160A (en) * 1990-10-12 1992-04-28 E. I. Du Pont De Nemours And Company Sterilizable radionuclide generator and method for sterilizing the same
US20050116186A1 (en) * 2002-04-11 2005-06-02 Weisner Peter S. Radioisotope generator
US20080086025A1 (en) * 2004-09-03 2008-04-10 Van Der Lee Petrus Johannes Jo Radiation-Shielding Container Assemblies, Radioactive Material Administration Devices, And Methods Of Using The Same
US7425208B1 (en) * 2003-08-29 2008-09-16 Vitello Jonathan J Needle assembly facilitating complete removal or nearly complete removal of a composition from a container
US20080237502A1 (en) * 2005-07-27 2008-10-02 Fago Frank M System and Method of Identifying Eluant Amounts Supplied to a Radioisotope Generator

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA585065A (en) * 1956-02-13 1959-10-13 J. Prest Robert Shielded exchanger for radioactive sources
US3673411A (en) * 1970-03-03 1972-06-27 Nuclear Associates Inc Holder for radioactive material
US4020355A (en) * 1973-02-16 1977-04-26 E. R. Squibb & Sons, Inc. Receptacle for radioactive material
US4241728A (en) * 1978-11-27 1980-12-30 Stuart Mirell Method and apparatus for dispensing radioactive materials
US4560069A (en) * 1985-05-02 1985-12-24 Simon B Kenneth Package for hazardous materials
US4880119A (en) * 1987-04-06 1989-11-14 Simon B Kenneth Cushioned container for hazardous material
GB2382453B (en) * 2002-04-11 2004-05-19 Amersham Plc Radioisotope generator and method of construction thereof
US7199375B2 (en) * 2004-10-12 2007-04-03 Bard Brachytherapy, Inc. Radiation shielding container that encloses a vial of one or more radioactive seeds
JP4478803B2 (ja) * 2005-03-02 2010-06-09 独立行政法人放射線医学総合研究所 放射線遮蔽容器
CN101615436A (zh) * 2008-06-24 2009-12-30 上海同普放射防护设备有限公司 防辐射抽药罐
KR100882781B1 (ko) * 2008-08-27 2009-02-09 고려검사주식회사 방사선 피폭 저감을 위한 방사선원 식별보관 폐기함
KR101650978B1 (ko) * 2009-05-13 2016-08-24 랜티우스 메디컬 이메징, 인크. 방사성 핵종 생성기 및 무균화의 방법
CN102294081B (zh) * 2011-06-03 2014-10-29 山东新华医疗器械股份有限公司 流体辐照仪
US20130053815A1 (en) * 2011-08-23 2013-02-28 Allergan, Inc. High recovery vial adaptor

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3369121A (en) * 1966-04-06 1968-02-13 Squibb & Sons Inc Radioactive package and container therefor
US5109160A (en) * 1990-10-12 1992-04-28 E. I. Du Pont De Nemours And Company Sterilizable radionuclide generator and method for sterilizing the same
US20050116186A1 (en) * 2002-04-11 2005-06-02 Weisner Peter S. Radioisotope generator
US7425208B1 (en) * 2003-08-29 2008-09-16 Vitello Jonathan J Needle assembly facilitating complete removal or nearly complete removal of a composition from a container
US20080086025A1 (en) * 2004-09-03 2008-04-10 Van Der Lee Petrus Johannes Jo Radiation-Shielding Container Assemblies, Radioactive Material Administration Devices, And Methods Of Using The Same
US20080237502A1 (en) * 2005-07-27 2008-10-02 Fago Frank M System and Method of Identifying Eluant Amounts Supplied to a Radioisotope Generator

Also Published As

Publication number Publication date
JP2016537649A (ja) 2016-12-01
CA2927365A1 (en) 2015-05-07
ZA201602676B (en) 2017-07-26
AU2014342210B2 (en) 2019-05-30
KR20160077090A (ko) 2016-07-01
CN105684092A (zh) 2016-06-15
JP6549138B2 (ja) 2019-07-24
AU2014342210A1 (en) 2016-05-05
EP3063770B1 (en) 2018-11-28
CA2927365C (en) 2021-09-21
US9281089B2 (en) 2016-03-08
EP3063770A4 (en) 2017-10-18
EP3063770A1 (en) 2016-09-07
KR102325245B1 (ko) 2021-11-15
CN105684092B (zh) 2018-03-27
US20150179289A1 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
US9336912B2 (en) Product cartridge for radionuclide
CN102119252B (zh) 用于向患者递送流体注射药丸以及处理有害流体的装置和方法
US9281089B2 (en) Parent radionuclide container
JP4974250B2 (ja) ラジオアイソトープジェネレータ
EP2375421B1 (en) Column geometry to maximize elution efficiencies for molybdenum-99
MXPA04009980A (es) Generador de radioisotopos y metodo de construccion del mismo.
US20150165341A1 (en) Separator cartridge for radionuclide
RU2546731C1 (ru) Генератор рубидия-82 и способ его приготовления
US20240177880A1 (en) Terminally sterilized alpha-emitting isotope generator and method for producing terminally sterilized alpha-emitting isotope
US12293848B2 (en) Coaxial needle Technetium elution generator
JP2008139272A (ja) 放射性同位元素を生成するシステムおよび方法
JP6301195B2 (ja) ルアーコネクタ及び薬剤注入装置
CA3253079A1 (en) DEVICE FOR PACKAGING PRODUCTS, PARTICULARLY FOOD PRODUCTS
KR20130023515A (ko) 99m-Tc 발생기용 칼럼 모듈, 시스템 및 이를 이용한 99m-Tc 추출 방법
WO2009029602A1 (en) Valved radioisotope generator

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14857501

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2927365

Country of ref document: CA

REEP Request for entry into the european phase

Ref document number: 2014857501

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2016552238

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2014342210

Country of ref document: AU

Date of ref document: 20141030

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 20167012470

Country of ref document: KR

Kind code of ref document: A